MarginsXMarginsX
Home › Markets › VYCO

Vycor Medical Inc (VYCO)

VYCO is quoted over the counter, not listed on an exchange. Vycor Medical Inc files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Last trade · November 12, 2026
$0.0440
No trades since Nov 12, 2026; later closes repeat the last quote
1-year return
-74.9%
Market cap
$1.5M
Nano cap. From the Nov 12, 2026 last trade × 33.4M shares (10-Q cover page, Nov 13, 2026)
P/E and P/S
Net loss over the period · 0.8×
On trailing twelve months to June 30, 2026 (10-Q)

Closes: Yahoo Finance daily closes, last bar 2026-11-13.

Profile

FieldValue
TickerVYCO, quoted over the counter
SEC CIK0001424768
OTC Markets tierOTCQB (price source, 2026-11-13)
SEC industry codeSurgical & Medical Instruments & Apparatus
Business addressBoca Raton,, FL
Incorporated inDE

Warning signs

Cash runway
Cash-flow positive
$159K cash at June 30, 2026
Share count, 1 year
0.0%
2025-11-14 to 2026-11-13 · +2.3% over 3 years
Going-concern doubt
Yes
10-Q filed November 13, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These conditions, among others, raise substantial doubt regarding our ability to continue as a going concern."
10-Q 2026-11-13
Cash and burn$159K cash; operating cash flow $15K a quarter.Report 2026-06-30
Shares outstanding33,372,796 (2026-11-13); 33,372,796 a year earlier; 32,628,835 three years earlier.Cover page 2026-11-13
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorPrager Metis CPAs, LLC, Hackensack, New Jersey, United StatesPCAOB Form AP 2026-04-10
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
$418K-$22K-$5K$159K$304K$1.8M10-Q 2026-08-14
Q1 2026
2026-03-31
$459K$20K$99K$174K$313K$1.9M10-Q 2026-05-15
Q4 2025
2025-12-31
$417K-$63K$39K$87K$327K$1.9M10-K 2026-03-31
Q3 2025
2025-09-30
$514K$5K-$72K$64K$341K$1.9M10-Q 2025-11-14
Q2 2025
2025-06-30
$496K$24K$47K$100K$303K$1.8M10-Q 2026-08-14
Q1 2025
2025-03-31
$436K-$39K-$27K$61K$308K$1.7M10-Q 2026-05-15
Q4 2024
2024-12-31
$455K-$7K-$38K$106K$324K$1.6M10-K 2026-03-31
Q3 2024
2024-09-30
$391K-$60K$10K$158K$337K$1.4M10-Q 2025-11-14

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32016-10-21
Latest annual report10-K2026-03-31
Latest quarterly / interim10-Q2026-11-13
Latest current report8-K2026-11-16

Source: SEC EDGAR submissions feed, 464 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier